Abstract
We report the clinical experience gained with interferon treatment of B and T cell neoplasms, as well as of myeloproliferative and myelodysplastic syndromes.
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Cell Division / drug effects
-
Cell Membrane / drug effects
-
Drug Evaluation
-
Hematologic Diseases / drug therapy*
-
Humans
-
Interferons / adverse effects
-
Interferons / pharmacology
-
Interferons / therapeutic use*
-
Killer Cells, Natural / drug effects
-
Lymphoma, Non-Hodgkin / drug therapy
-
Multiple Myeloma / drug therapy
-
Myelodysplastic Syndromes / drug therapy
-
Recombinant Proteins / pharmacology
-
Recombinant Proteins / therapeutic use
Substances
-
Antineoplastic Agents
-
Recombinant Proteins
-
Interferons